Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,113 | 80 | 98.7% |
| Education | $14.90 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $190.08 | 13 | $0 (2023) |
| Novo Nordisk Inc | $134.03 | 10 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $117.58 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $70.45 | 6 | $0 (2019) |
| Shire North American Group Inc | $69.65 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $68.32 | 6 | $0 (2018) |
| Amgen Inc. | $61.16 | 5 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $54.95 | 4 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $46.45 | 3 | $0 (2019) |
| Lilly USA, LLC | $45.04 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.91 | 1 | ABBVIE INC. ($24.91) |
| 2023 | $25.84 | 1 | PFIZER INC. ($25.84) |
| 2020 | $69.17 | 5 | PFIZER INC. ($27.46) |
| 2019 | $341.75 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.50) |
| 2018 | $348.38 | 26 | PFIZER INC. ($43.27) |
| 2017 | $317.55 | 25 | PFIZER INC. ($63.88) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: VACCINES | ||||||
| 10/07/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/23/2020 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/20/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Bone Health | ||||||
| 10/02/2019 | PFIZER INC. | CELEBREX (Drug), LYRICA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFLAMMATION;ONCOLOGY;PAIN | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: DIABETES | ||||||
| 07/10/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 05/13/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Diabetes | ||||||
| 05/01/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DIABETES | ||||||
| 04/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 04/17/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neuroscience | ||||||
| 04/03/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: UROLOGY | ||||||
| 03/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/27/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 229 | 258 | $28,748 | $10,964 |
| 2021 | 10 | 807 | 1,349 | $139,286 | $78,816 |
| 2020 | 15 | 971 | 1,499 | $163,560 | $78,133 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 142 | $15,052 | $4,934 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $6,870 | $3,893 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 32 | $4,736 | $1,296 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $1,425 | $501.95 | 35.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 35 | $665.00 | $339.85 | 51.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 208 | 583 | $61,798 | $35,518 | 57.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 136 | 136 | $31,144 | $17,766 | 57.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 194 | $28,712 | $13,570 | 47.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 64 | 64 | $3,968 | $3,968 | 100.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 49 | 53 | $3,975 | $2,100 | 52.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 70 | 163 | $3,097 | $1,583 | 51.1% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 34 | 35 | $1,750 | $1,329 | 76.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 35 | 35 | $1,750 | $1,329 | 76.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 74 | 74 | $2,442 | $1,198 | 49.1% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 12 | 12 | $650.00 | $455.76 | 70.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 213 | 509 | $53,954 | $24,171 | 44.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 168 | 297 | $43,956 | $19,933 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 158 | 158 | $36,182 | $17,969 | 49.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 65 | 66 | $4,092 | $3,945 | 96.4% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 14 | 14 | $3,920 | $2,042 | 52.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 17 | 17 | $2,142 | $1,999 | 93.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 35 | 38 | $5,390 | $1,829 | 33.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 72 | 158 | $3,002 | $1,526 | 50.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 77 | 78 | $2,574 | $1,253 | 48.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 36 | 41 | $3,615 | $1,162 | 32.1% |
About Dr. Michael Badik, DO
Dr. Michael Badik, DO is a Family Medicine healthcare provider based in Fostoria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1720253438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Badik, DO has received a total of $1,128 in payments from pharmaceutical and medical device companies, with $24.91 received in 2024. These payments were reported across 81 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,113).
As a Medicare-enrolled provider, Badik has provided services to 2,007 Medicare beneficiaries, totaling 3,106 services with total Medicare billing of $167,914. Data is available for 3 years (2020–2022), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fostoria, OH
- Active Since 04/23/2008
- Last Updated 05/02/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720253438
Products in Payments
- CHANTIX (Drug) $80.67
- JARDIANCE (Drug) $57.60
- Ozempic (Drug) $54.12
- FARXIGA (Drug) $48.35
- REXULTI (Drug) $46.45
- MYDAYIS (Drug) $43.93
- JANUVIA (Drug) $41.84
- XIFAXAN (Drug) $39.48
- Victoza (Drug) $38.29
- VRAYLAR (Drug) $36.78
- ENTRESTO (Drug) $33.67
- SPIRIVA RESPIMAT (Drug) $33.09
- STIOLTO (Drug) $32.43
- TOUJEO (Drug) $31.48
- Saxenda (Drug) $25.88
- PREVNAR 20 (Biological) $25.84
- VIAGRA (Drug) $25.27
- TRELEGY ELLIPTA (Drug) $23.57
- SOLIQUA (Drug) $23.47
- Prolia (Biological) $23.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fostoria
Dr. Jill Badik, Do, DO
Family Medicine — Payments: $1,788
Dr. Samantha Carson, Do, DO
Family Medicine — Payments: $752.42
Mr. Tim Beidelschies, Md, MD
Family Medicine — Payments: $92.70
Alisa Ingram, Md, MD
Family Medicine
Dr. Pramuan Thirasilpa, Md, MD
Family Medicine
Edwin Davis, Md, MD
Family Medicine